Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.120
+0.030 (1.44%)
Feb 17, 2026, 1:22 PM EST - Market open
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $102.41 million as of February 17, 2026. Its market cap has decreased by -10.56% in one year.
Market Cap
102.41M
Enterprise Value
-5.12M
1-Year Change
-10.56%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $102.41M, a decrease of -51.83%. That is a compound annual growth rate of -2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 100.96M | 5.56% |
| Dec 31, 2025 | 95.65M | -15.76% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 108.17M |
| Cardiff Oncology | 107.78M |
| Alpha Cognition | 106.10M |
| Korro Bio | 105.19M |
| Turn Therapeutics | 103.35M |
| Dogwood Therapeutics | 102.22M |
| Actuate Therapeutics | 100.64M |
| Agenus | 99.30M |